Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

Authors Hataji O, Naito M, Ito K, Watanabe F, Gabazza E, Taguchi O

Received 26 September 2012

Accepted for publication 19 November 2012

Published 28 December 2012 Volume 2013:8 Pages 1—5

DOI https://doi.org/10.2147/COPD.S38548

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 5

Osamu Hataji,1 Masahiro Naito,1 Kentaro Ito,1 Fumiaki Watanabe,1 Esteban C Gabazza,2 Osamu Taguchi3

1Respiratory Center, Matsusaka Municipal Hospital, Tonomachi, 2Department of Immunology, 3Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, Mie, Japan

Background: The current mainstay of therapy for chronic obstructive pulmonary disease (COPD) is long-acting bronchodilators. To date, the effect of indacaterol, a β2-agonist, on activities of daily living in COPD patients is not well understood. The aim of this study was to evaluate the efficacy of indacaterol with regard to activities of daily living in patients with COPD.
Methods: In this nonrandomized open-label study, 23 patients with COPD were instructed to carry an accelerometer for 4 weeks without indacaterol therapy and then for another period of 4 weeks while receiving indacaterol therapy.
Results: The number of steps, duration of moderate or greater physical activity, and energy expenditure were significantly increased after treatment with indacaterol compared with baseline data in all patients with COPD; the metabolic equivalent of task was also significantly enhanced after treatment with indacaterol.
Conclusion: This study provides early evidence that indacaterol improves daily physical activity in patients with COPD.

Keywords: chronic obstructive pulmonary disease, indacaterol, long-acting β2-agonist, physical activity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]